President Trump says, "Eli Lilly, Merck, Pfizer, they're all building massive billions, hundreds of billions of dollars worth of plants. It's all coming back." 🇺🇸 What happened here is worth understanding clearly because it represents the single largest pharmaceutical reshoring movement in history, and it did not happen by accident. For decades, every administration watched the pharmaceutical industry hollow out its U.S. manufacturing base, shipping production to Ireland, India, Singapore, and China because labor and regulatory costs were lower. Polite incentives, tax credits, and endless discussions produced nothing close to what Trump’s tariff leverage achieved. Pfizer committed $70 billion. Merck pledged over $70 billion and is already building in Virginia, Delaware, and North Carolina. Lilly is constructing four new plants.